Oligodeoxyribonucleotides, Antisense
"Oligodeoxyribonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
| Descriptor ID |
D020319
|
| MeSH Number(s) |
D13.150.200.640 D13.150.480.640 D13.444.308.150.640 D13.444.600.150.200.640 D13.444.600.150.640.640 D13.695.578.424.480.640 D27.720.470.530.600.150.200.640 D27.720.470.530.600.150.640.640
|
| Concept/Terms |
Oligodeoxyribonucleotides, Antisense- Oligodeoxyribonucleotides, Antisense
- Antisense OligoDNA
- OligoDNA, Antisense
- Anti-Sense Oligodeoxyribonucleotides
- Anti Sense Oligodeoxyribonucleotides
- Oligodeoxyribonucleotides, Anti-Sense
- Oligodeoxyribonucleotide, Antisense
- Antisense Oligodeoxyribonucleotide
- Antisense Oligodeoxyribonucleotides
|
Below are MeSH descriptors whose meaning is more general than "Oligodeoxyribonucleotides, Antisense".
- Chemicals and Drugs [D]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Antisense Elements (Genetics) [D13.150]
- DNA, Antisense [D13.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.150.200.640]
- Oligonucleotides, Antisense [D13.150.480]
- Oligodeoxyribonucleotides, Antisense [D13.150.480.640]
- Nucleic Acids [D13.444]
- DNA [D13.444.308]
- DNA, Antisense [D13.444.308.150]
- Oligodeoxyribonucleotides, Antisense [D13.444.308.150.640]
- Nucleic Acid Probes [D13.444.600]
- Antisense Elements (Genetics) [D13.444.600.150]
- DNA, Antisense [D13.444.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.200.640]
- Oligonucleotides, Antisense [D13.444.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.640.640]
- Nucleotides [D13.695]
- Polynucleotides [D13.695.578]
- Oligonucleotides [D13.695.578.424]
- Oligonucleotides, Antisense [D13.695.578.424.480]
- Oligodeoxyribonucleotides, Antisense [D13.695.578.424.480.640]
- Chemical Actions and Uses [D27]
- Specialty Uses of Chemicals [D27.720]
- Laboratory Chemicals [D27.720.470]
- Molecular Probes [D27.720.470.530]
- Nucleic Acid Probes [D27.720.470.530.600]
- Antisense Elements (Genetics) [D27.720.470.530.600.150]
- DNA, Antisense [D27.720.470.530.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.200.640]
- Oligonucleotides, Antisense [D27.720.470.530.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.640.640]
Below are MeSH descriptors whose meaning is more specific than "Oligodeoxyribonucleotides, Antisense".
This graph shows the total number of publications written about "Oligodeoxyribonucleotides, Antisense" by people in this website by year, and whether "Oligodeoxyribonucleotides, Antisense" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 0 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oligodeoxyribonucleotides, Antisense" by people in Profiles.
-
Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability. J Clin Invest. 2016 Apr 01; 126(4):1236-8.
-
Interferon-gamma-dependent inhibition of late allergic airway responses and eosinophilia by CD8+ gammadelta T cells. Immunology. 2007 Oct; 122(2):230-8.
-
Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann Neurol. 2004 Mar; 55(3):347-52.
-
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
-
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 2003 Jun 15; 63(12):3043-8.
-
Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
-
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer. Clin Cancer Res. 2001 May; 7(5):1214-20.
-
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
-
Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors. J Biol Chem. 2000 Sep 08; 275(36):27520-30.
-
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. J Toxicol Clin Toxicol. 2000; 38(4):383-7.